HellmanLMHertigAT.Pathological changes in the placenta associated with erythroblastosis of the fetus. Am J Path1938; 14: 111.
3.
LandsteinerKWienerAS.An agglutinable factor in human blood recognised by immune sera for Rhesus blood. Proceedings of the Society for Experimental Biology and Medicine1940; 43: 223.
4.
LevinePKatzinEMBurnhamL.Isoimmunisation in pregnancy: its bearing on the aetiology of erythroblastosis fetalis. JAMA1941; 116: 825.
5.
LandsteinerKWienerAS.Studies on an agglutinogen (Rh) in human blood reacting with anti-Rhesus sera and with human iso-antibodies. J Exper Med1941; 74: 309.
6.
DiamondLK.Erythroblastosis fetalis or haemolytic disease of the newborn. Proceedings of the Royal Society of Medicine1947; 40: 546.
7.
WallersteinH.Treatment of severe erythroblastosis by simultaneous removal and replacement of blood of newborn infant. Science1946; 103: 595.
8.
WalkerWMurraySFairweatherDVI.Haemolytic disease of the newborn at the crossroads. Newcastle Medical Journal1966; 29: 142.
9.
BevisDCA.The antenatal prediction of haemolytic disease of the newborn. Lancet1952; i: 395.
10.
LileyAW.Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitisation. Am J Obstet Gynecol1961; 82: 1359.
11.
LileyAW.Intrauterine transfusion of fetus in haemolytic disease. B Med J1963; 2: 1107.
12.
HobbinsJCDavisCDWebsterJ.A new technique utilising ultrasound to aid intrauterine transfusion. J Clin Ultrasound1976; 4: 135.
13.
British Medical Journal. Prevention of Rh haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore. BMJ1966; 2: 907.
14.
Consensus statement from the Royal College of Physicians of Edinburgh / Royal College of Obstetricians and Gynaecologists. Consensus Conference on Anti-D Prophylaxis 7 & 8 April 1997. Transfus Med1977; 7: 143–144.
15.
NelsonMForsythCPoppHGibsonJ.Rapid detection of Rh(D)-or K-positive cells in chorion villus samples by a flow cytometric technique. Transfus Med1994; 4: 297–302.
16.
BennettPRLe Van KimCColinY: Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med1993; 329: 607–610.
17.
RCOG Working Party. Fetal Awareness: Report of a Working Party. RCOG Press1997 rcog press 1997;.
18.
BussellJKaplanCMcFarlandJ.Recommendations for the evaluation and diagnosis of neonatal autoimmune and alloimmune thrombocytopenia. Thromb Haemost1991; 65: 631–634.
19.
Mueller-EckhardtCKiefelVGrubertA348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet1989; i: 362–366.
20.
KaplanCDaffosFForestierFCurrent trends in neonatal alloimmune thrombocytopenia: diagnosis and therapy. In: Kaplan-GuoetCShlegelMSalmonCMcGregorJ, eds. Platelet immunology: fundamental and clinical aspects. London: Colloqui INSERM/John Libbey Eurotext, 1991: 267–278.
21.
HermanJHJumbelicMIAnconaRJKicklerTS.In utero cerebral haemorrhage in alloimmune thrombocytopenia. Am J Pediatr Hematol Oncol1986; 8: 312–317.
22.
MullerJYReznikoff-EtievantMFPatereauCThrombopenies neo-natales allo-immunes: Etude clinique et biologique de 84 cas. Presse Med1985; 14: 83–86.
23.
DeaverJELeppertPCZaroulisCG.Neonatal alloimmune thrombocytopenic purpura. Am J Perinat1986; 3: 127–131.
24.
NicoliniUTannirandornYGonzalesP.Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinaemia fails to prevent thrombocytopenia. Am J Obstet Gynecol1990; 163: 1144–1146.
25.
GruelYBiozardBDaffosF.Determination of platelet antigens and glycoproteins in the human fetus. Blood1986; 68: 488–492.
26.
KaplanCDaffosFForestierFManagement of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood1988; 72: 340–343.
27.
PaidasMJBerkowitzRLLynchLAlloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol1995; 172: 475–479.
28.
BusselJBBerkowitzRLMcFarlandJGAntenatal treatment of neonatal alloimmune thrombocytopenia. N Eng J Med1988; 319: 1374–1378.
29.
LynchLBusselJBMcFarlandJGAntenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol1992; 80: 67–71.
30.
MirNSamsonDHouseMJFailue of antenatal high-dose immunoglobulin to improve fetal platelet count in neonatal alloimmune thrombocytopenia. Vox Sang1988; 55: 188–189.
31.
BussellJBBerkowitzRLLynchLAntenatal treatment of alloimmune thrombocytopenia with intravenous g-globulin: A randomised trial of the addition of low-dose steroid to intravenous g-globulin. Am J Obstet Gynecol1996; 174: 1414–1423.
32.
RobertsonEGNeerKJ.Placental injection studies in twin gestation. Am J Obstet Gynecol1983; 147: 170–174.
33.
PattenRMMackLAHarveyDCyrDRPretoriusDH.Disparity of amniotic fluid volume and fetal size: problem of the stuck twin- US Studies. Radiology1989; 172: 153–157.
34.
WeinerCPLudomirskiA.Diagnosis, pathophysiology, and treatment of chronic twin-to twin transfusion syndrome. Fetal Diagn Ther1994; 9: 283–290.
35.
SteinbergLHHurleyVADesmedtEBeischerNA.Acute polyhydramnios in twin pregnancies. Aust N Z J Obstet Gynaecol1990; 30: 196–200.
36.
ReisnerDPMahonyBSPettyCNStuck twin syndrome: outcome in thirty-seven consecutive cases. Am J Obstet Gynecol1993; 169: 991–995.
37.
BajoriaRWigglesworthJFiskNM.Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome. Am J Obstet Gynecol1995; 172 (3):856–863.
SnijdersRJAbbasAMelbyOIrelandRMNicolaidesKH.Fetal plasma erythropoietin concentration in severe growth retardation. Am J Obstet Gynecol1993; 168: 615–619.
41.
CarrollSGMcLennanAMaxwellDJ.Fetal haemoglobin changes in the twin oligohydramnios-polyhydramnios sequence. Ultrasound Obstet Gynaecol1997; 9 (6):398–402.
SaundersNJSnijdersRJNicolaidesKH.Therapeutic amniocentesis in twin-twin transfusion syndrome appearing in the second trimester of pregnancy. Am J Obstet Gynecol1992; 166: 820–824.
44.
WittmanBKFarquharsonDFThomasWDBaldwinVJWadsworthLD.The role of fetocide in the management of severe twin transfusion syndrome. Am J Obstet Gynecol1986; 155: 1023–1026.
45.
QuinteroRALanouetteJCarrenoCAPercutaneous ligation and transection of the umbilical cord in complicated monoamniotic twin gestations via operative fetoscopy. Am J Obstet Gynecol1997; 176 (1):19.
46.
ScottFHindFBoogertA.Resolution of hydrops in twin-twin transfusion syndrome: could steroids have a role?Prenat Diagn1997; 17 (5):467–470.
47.
RomanJDHareAA.Digoxin and decompression amniocentesis for treatment of feto-fetal transfusion. Br J Obstet Gynaecol1995; 102: 421–423.
48.
KirshonBMariGMoiseK.Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol1990; 75: 202–205.
49.
LangeIRHarmanCRAshKMManningFAMenticoglouS.Twin with hydramnios: treating premature labor at source. Am J Obstet Gynecol1989; 160: 552–557.
50.
BowerSJFlackNJSepulvedaWTalbertDGFiskNM.Uterine artery blood flow response to correction of amniotic fluid volume. Am J Obstet Gynecol1995; 173 (2):502–507.
51.
MeagherSTippettCRenouPBakerLSusilB.Twin-twin transfusion syndrome: intaamniotic pressure measurement in the assessment of volume reduction at serial amniocenteses. Aust N Z J Obstet Gynaecol1995; 35 (1):22–26.
52.
PinetteMGPanYPinetteSGStubblefieldPG.Treatment of twin-twin transfusion syndrome. Obstet Gynecol1993; 82: 841–846.
53.
ElliottJPUrigMAClewellWH.Aggressive therapeutic amniocentesis for treatment of twin-twin transfusion syndrome. Obstet Gynecol1991; 77 (4):537–540.
54.
MahoneyBSPettyCNNybergDALuthyDAHickokDEHirschJH.The ‘stuck twin’ phenomenon: ultrasonic findings, pregnancy outcome, and management with serial amniocentesis. Am J Obstet Gynecol1990; 163: 1513–1522
55.
ElliotJPUrigMAClewellWH.Aggressive therapeutic amniocentesis for treatment of twin-twin transfusion syndrome. Obstet Gynecol1991; 77: 537–540.
56.
UrigMAClewellWHElliottJP.Twin-twin transfusion syndrome. Am J Obstet Gynecol1990; 163: 1522–1566.
57.
KilbyMDHoweDTMcHugoJMWhittleMJ.Bladder visualisation as a prognostic sign in oligohydramnios-polyhydramnios sequence in twin pregnancies treated using therapeutic amniocentesis. Br J Obstet Gynaecol1997; 104 (8):939–942.
58.
VilleYSiderisINicolaidesKH.Amniotic fluid pressure in twin-to twin transfusion syndrome: an objective prognostic factor. Fetal Diagn Ther1997; 11 (3):176–180.
59.
SaadeGROlsonGBelfortMAMoiseKJ.Amniotomy: a new approach to the ‘stuck twin’ syndrome. Am J Obstet Gynecol1995; 172: 429.
60.
DruganASynerFNGrebAEvansMI.Amniotic fluid alphafetoprotein and acetylcholinesterase in early genetic amniocentesis. Obstet Gynecol1988; 72: 35–38.
61.
BerryDMontgomeryLJohnsonASaadeGMoiseK.Amniotic septostomy for the treatment of the stuck twin sequence. Am J Obstet Gynecol1997; 176 (1):19.
62.
VilleYHyettJHecherKNicolaidesK.Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome. N Eng J Med1995; 332 (4):224–227.
63.
VilleYVan PeborghPGagnonAFrydmanRFernandezH.Surgical treatment of twin-to twin transfusion syndrome: coagulation of anastomoses with a Nd:YAG laser, under endosonagraphic control. Forty four cases. J Gynecol Obstet Biol Reprod1997; 26 (2):175–181.
64.
De LiaJEKuhlmannRSHarstadTWCruikshankDP.Fetoscopic laser ablation of placental vessels in severe previable twin-twin transfusion syndrome. Am J Obstet Gynecol1995; 1702: 1202–1211.
65.
CincottaROldhamJSampsonA.Antepartum and postpartum complications of twin-twin transfusion. Aust N Z J Obstet Gynaecol1996; 36 (3):303–308.
66.
RCOG.Termination of pregnancy for fetal abnormality in England, Wales and Scotland. Royal College of Obstetricians & Gynaecologists1996;.
PetrokovskyBVintzileosA.Management and outcome of multiple pregnancies of higher fetal order: Literature review. Obstet Gynecol Surv1989; 44: 578.
69.
EvansMIMayMDruganASelective termination: Clinical experience and residual risks. Am J Obstet Gynecol1990; 162: 1568–1575.
70.
EvansMIDommerguesMWagnerRJEfficacy of transabdominal multifetal pregnancy reduction: Collaborative experience of the world's largest centers. Obstet Gynecol1993; 82: 61–66.
71.
KarsonEMAndersonWF.Prospects for Gene Therapy. In: HarrisonGolbusFilly, eds. The Unborn Patient.241st ed.Philadelphia: Saunders, 1991: 481–494.
72.
CrombleholmeTMZanjaniEDLangerJCHarrisonMR.Transplantation of Fetal Cells. In: HarrisonGolbusFilly, eds. The Unborn Patient.2nd ed.Philadelphia: Saunders, 1991: 495–507.
73.
ClarkSLVitaleDJMintonSDSuccessful fetal therapy for cystic adenomatoid malformation associated with second trimester hydrops. Am J Obstet Gynecol1987; 157: 294.
74.
TeohTRyanGJohnsonJMWinsorEJT.The role of fetal karyotyping from unconventional sources. Am J Obstet Gynecol1996; 175: 873–877.